These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25490865)

  • 41. Initial study of transdermal oxybutynin for treating hyperhidrosis.
    Millán-Cayetano JF; Del Boz J; Toledo-Pastrana T; Nieto-Guindo M; García-Montero P; de Troya-Martín M
    J Dermatol; 2017 Jun; 44(6):717-720. PubMed ID: 28106275
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term comparison of video-assisted thoracic sympathectomy and clinical observation for the treatment of palmar hyperhidrosis in children younger than 14.
    Neves S; Uchoa PC; Wolosker N; Munia MA; Kauffman P; de Campos JR; Puech-Leão P
    Pediatr Dermatol; 2012; 29(5):575-9. PubMed ID: 22486301
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preliminary Experience with Transdermal Oxybutynin Patches for Hyperhidrosis.
    Bergón-Sendín M; Pulido-Pérez A; Sáez-Martín LC; Suárez-Fernández R
    Actas Dermosifiliogr; 2016 Dec; 107(10):845-850. PubMed ID: 27497508
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Evaluation of the long-term results of surgical treatment of palmar hyperhidrosis].
    Laín A; García-Casillas MA; Fanjul M; Corona C; Tardáguila A; Matute JA
    Cir Pediatr; 2010 Jul; 23(3):153-6. PubMed ID: 23155661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Symptoms of anxiety and depression in patients with primary hyperhidrosis and its association with the result of clinical treatment with oxybutynin.
    Kamikava DYF; Wolosker N; Silva MFAD; Campos JRM; Puech-Leão P
    Clinics (Sao Paulo); 2021; 76():e2892. PubMed ID: 34190853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy, Safety and Quality of Life of Oxybutynin versus Aluminum Chloride Hexahydrate in Treating Primary Palmar Hyperhidrosis.
    Attallah HS; El-Gilany AH; Youssef YEB; Abdelshaheed ME; Sharaf EFA
    Indian J Dermatol; 2022; 67(3):222-227. PubMed ID: 36386101
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methadone-Induced Hyperhidrosis Treated With Oxybutynin.
    Hong J; Lee J; Totouom-Tangho H; Dunn NR; Swift RG
    J Addict Med; 2017; 11(3):237-238. PubMed ID: 28244893
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of botulinum toxin-a therapy for palmar hyperhidrosis in plantar sweat production.
    Gregoriou S; Rigopoulos D; Makris M; Liakou A; Agiosofitou E; Stefanaki C; Kontochristopoulos G
    Dermatol Surg; 2010 Apr; 36(4):496-8. PubMed ID: 20180837
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oxybutynin as an alternative treatment for hyperhidrosis.
    Delort S; Marchi E; Corrêa MA
    An Bras Dermatol; 2017; 92(2):217-220. PubMed ID: 28538882
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glycopyrrolate-induced craniofacial compensatory hyperhidrosis successfully treated with oxybutynin: report of a novel adverse effect and subsequent successful treatment.
    Prouty ME; Fischer R; Liu D
    Dermatol Online J; 2016 Oct; 22(10):. PubMed ID: 28329602
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Palmar hyperhidrosis: long-term follow-up of nine children and adolescents treated with botulinum toxin type A.
    Coutinho dos Santos LH; Gomes AM; Giraldi S; Abagge KT; Marinoni LP
    Pediatr Dermatol; 2009; 26(4):439-44. PubMed ID: 19689521
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oxybutynin efficacy in the treatment of primary enuresis.
    Lovering JS; Tallett SE; McKendry JB
    Pediatrics; 1988 Jul; 82(1):104-6. PubMed ID: 3288951
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyperhidrosis Substantially Reduces Quality of Life in Children: A Retrospective Study Describing Symptoms, Consequences and Treatment with Botulinum Toxin.
    Mirkovic SE; Rystedt A; Balling M; Swartling C
    Acta Derm Venereol; 2018 Jan; 98(1):103-107. PubMed ID: 28761964
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Superiority of thoracoscopic sympathectomy over medical management for the palmoplantar subset of severe hyperhidrosis.
    Baumgartner FJ; Bertin S; Konecny J
    Ann Vasc Surg; 2009; 23(1):1-7. PubMed ID: 18619780
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
    Rosell K; Hymnelius K; Swartling C
    Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Endoscopic thoracic sympathectomy for palmar, axillary and plantar hyperhidrosis: intermediate-term results].
    Fukushima H; Makimura S; Takae H; Yao Y; Ishimaru S
    Kyobu Geka; 2001 May; 54(5):379-83. PubMed ID: 11357300
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effects of long-term administration of oxybutynin hydrochloride (KL007) for the treatment of neurogenic bladder and unstable bladder].
    Sonoda T; Sakurai T; Yamada K; Mizutani S; Tsujimoto Y; Ogawa T
    Hinyokika Kiyo; 1989 Jan; 35(1):167-78. PubMed ID: 2658513
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Anticholinergic treatment in the therapy of primary enuresis. Effectiveness of oxybutynin chloride in a controlled clinical study of 58 patients].
    Marconi AM; Felici E; Roggia A; Torelli F
    Pediatr Med Chir; 1985; 7(4):573-6. PubMed ID: 3915547
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oxybutynin for hyperhidrosis.
    Lefrandt JD; Maurer JM
    Neth J Med; 2007 Oct; 65(9):356. PubMed ID: 17954957
    [No Abstract]   [Full Text] [Related]  

  • 60. Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships.
    Gupta SK; Sathyan G; Lindemulder EA; Ho PL; Sheiner LB; Aarons L
    Clin Pharmacol Ther; 1999 Jun; 65(6):672-84. PubMed ID: 10391673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.